Αρχειοθήκη ιστολογίου

Παρασκευή 1 Ιανουαρίου 2016

Review of carcinogenicity of asbestos and proposal of approval standards of an occupational cancer caused by asbestos in Korea.

Review of carcinogenicity of asbestos and proposal of approval standards of an occupational cancer caused by asbestos in Korea.

Ann Occup Environ Med. 2015;27:34

Authors: Im S, Youn KW, Shin D, Lee MJ, Choi SJ

Abstract
Carcinogenicity of asbestos has been well established for decades and it has similar approval standards in most advanced countries based on a number of studies and international meetings. However, Korea has been lagging behind such international standards. In this study, we proposed the approval standards of an occupational cancer due to asbestos through intensive review on the Helsinki Criteria, post-Helsinki studies, job exposure matrix (JEM) based on the analysis of domestic reports and recognized occupational lung cancer cases in Korea. The main contents of proposed approval standards are as follows; ① In recognizing an asbestos-induced lung cancer, diagnosis of asbestosis should be based on CT. In addition, initial findings of asbestosis on CT should be considered. ② High Exposure industries and occupations to asbestos should be also taken into account in Korea ③ An expert's determination is warranted in case of a worker who has been concurrently exposed to other carcinogens, even if the asbestos exposure duration is less than 10 years. ④ Determination of a larynx cancer due to asbestos exposure has the same approval standards with an asbestos-induced lung cancer. However, for an ovarian cancer, an expert's judgment is necessary even if asbestosis, pleural plaque or pleural thickening and high concentration asbestos exposure are confirmed. ⑤ Cigarette smoking status or the extent should not affect determination of an occupational cancer caused by asbestos as smoking and asbestos have a synergistic effect in causing a lung cancer and they are involved in carcinogenesis in a complicated manner.

PMID: 26719804 [PubMed]



from #ENT-PubMed via ola Kala on Inoreader http://ift.tt/1kxv5sR
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου